Financials
- Market Capitalization 1.01 B
- Employee 260
- Founded 2014
- CEO N/A
- Website www.kuraoncology.com
- Headquarter Delaware, United States
- FIGI BBG008974342
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-3.27
Fiyat/satışlar oranı
13.5
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2482 | JANX Janux Therapeutics, Inc. - Common Stock | 15.98 USD | -0.99% | -0.37% | +16.73% | -40.04% | 974.53 M USD | ||
| 2483 | AVTX Avalo Therapeutics, Inc. - Common Stock | 18.94 USD | +0.16% | -4.00% | +26.18% | +285.74% | 995.59 M USD | ||
| 2497 | ANRO Alto Neuroscience, Inc. Common Stock | 27.55 USD | -1.71% | +5.72% | +28.02% | +912.87% | 966.84 M USD | ||
| 2500 | PHAR Pharming Group N.V. - ADS, each representing 10 | 13.30 USD | -3.27% | -7.12% | +1.14% | +27.64% | 933.23 M USD |